TENAX THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tenax Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Tenax Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 124 %, a 46.8% decline year-over-year.
  • Tenax Therapeutics, Inc. annual Return On Equity for 2023 was 65.8 %, a 79.4% decline from 2022.
  • Tenax Therapeutics, Inc. annual Return On Equity for 2022 was 319 %.
  • Tenax Therapeutics, Inc. annual Return On Equity for 2021 was -809 %, a 279% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 65.8 -254 -79.4% Jan 1, 2023 Dec 31, 2023
2022 319 +1.13K Jan 1, 2022 Dec 31, 2022
2021 -809 -596 -279% Jan 1, 2021 Dec 31, 2021
2020 -213 -98.6 -85.9% Jan 1, 2020 Dec 31, 2020
2019 -115 +68.3 +37.3% Jan 1, 2019 Dec 31, 2019
2018 -183 -103 -130% Jan 1, 2018 Dec 31, 2018
2017 -79.6 +23.7 +23% Jan 1, 2017 Dec 31, 2017
2016 -103 Jan 1, 2016 Dec 31, 2016
2014 -48.1 -1.97K -103% May 1, 2014 Apr 30, 2015
2013 1.92K +1.34K +234% May 1, 2013 Apr 30, 2014
2012 574 May 1, 2012 Apr 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.